Biomarkers for Diabetes

"Biomarker", are designated "molecular marker" or a "signature particle". These markers gives the degree of illness as they lay outside calmly. HbA1c is considered a biomarker for a risk factor that is for retinopathy, nephropathy and other vascular sicknesses. Biomarkers empower preventive measures to be connected at the subclinical stage and the reactions to preventive or helpful measures to be observed. Cases in the course of recent decades have yielded test sets, for the most part blood products and urine from an expansive classification of patients with both type 1 and type 2 diabetes.

  • Carbonyl stress
  • Pulse wave analysis
  • Auto fluorescence
  • Biomarkers of vascular function in diabetes

Related Conference of Biomarkers for Diabetes

July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
September 16-17, 2019

International Conference on Diabetes and Heart diseases

Athens, Greece
September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
Nov 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
November 25-26, 2019

Annual Congress on Endocrinology, Diabetes and Healthcare

Bangkok,Thailand
December 02-03, 2019

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

| Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

| Holiday Inn Atrium | Singapore
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in